Avalon globocare achieves milestones in advancing novel intranasal and oral covid-19 vaccine candidate

Avalon globocare achieves milestones in advancing novel intranasal and oral covid-19 vaccine candidate.avalon globocare - partnership with university of natural resources and life sciences in vienna, austria.avalon globocare - partnership to develop an s-layer vaccine that can be administered by an intranasal or oral route against sars-cov-2.
AVCO Ratings Summary
AVCO Quant Ranking